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Abstract
Background: Osteoporosis is a major problem and is a hidden epidemic disease in the world.
Early diagnosis by measurement of Bone Mineral Density (BMD) and treatment can prevent and
reduce disease complications, especially fractures. As there is no comprehensive study in Iran, this
study designed to assess BMD discrepancy in 20–69 yr Tehran population as well as prevalence of
osteoporosis and osteopenia.
Methods: 553 people (34% men, 66%women) from 50 Blocks in Tehran randomly selected. The
assessment of BMD in spine and femur region performed through DXA method. All subjects
clinically examined and their BMIs determined.
Results: The average spinal BMD score in men were more than in women. The peak bone mass
of spine bone both in men and women occurred during 20–29 yr and reduction began from the age
of 40. At the age of 60 to 69, loose of bone density was 19.6% in lumbar spine and 18.5% in femur
of women and also 7.9% in lumbar spine and 14.6% in femur of men. Prevalence of osteoporosis in
this age group in lumbar spine and femur was 32.4% and 5.9% in women and 9.4% and 3.1% in men
respectively.
Conclusion: In all age groups, peak bone mass was lower than European or American population,
whereas the rate of bone loss was as much as the some population and actually this process justifies
the prevalence of osteoporosis and osteopenia in Tehran population.
Background
Osteoporosis is the most common metabolic disease of
bone which is known by deficit in bone mineral density
and skeletal micro destruction that increases risk of bone
fracture [1-3]. The importance of BMD is, in diagnosis of
osteoporosis and prevention of bone fractures and its con-
sequent disability [1,2]. BMD depends on age, disease,
genetic, mechanical factors, nutrition, and the body hor-
mones effects[4] Studies showed that the prevalence of
osteoporosis the age of over 70, it increases to 87% [5,6].
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In Thailand's over 70 yr women, prevalence of disease was
50% [6]. In the UK, 1/3 of women and 1/12 of men
affected from osteoporosis [7]. The investigations showed
that in the next 50 years, considering the population
growth in the old people in Asia, South America and
Africa, it is expected almost 75% of these fractures occur
in progressing countries [1]. A study, that recently per-
formed in Iran showed, osteoprotic fracture data was
important public health problem in Iran [8].
For reliable interpretation of individual BMD data, how-
ever, they need to be expressed in relation to established
normative data. Comparisons can be made either in terms
of the age-matched standard deviation score, use of the T
score, which indicates deviation from the mean BMD of a
young normal population [9]. For this reason, compari-
son of T scores yields the best available information on
the extent of osteoporotic bone loss and the associated
fracture risk.
In clinical practice, individual BMD values are compared
with a reference value. For diagnostic purposes, a panel
convened by the WHO proposed to define osteoporosis
on the basis of the T-score, According to this categories, a
T score between -1 and -2.5 is indicative of osteopenia,
while a T score -'-2· 5 reflects osteoporosis [9-12]. Despite
its limitations [13-15]; this definition is currently applied
worldwide. However, the normal values provided by
manufacturers may not be fully representative of specific
local populations. In fact, BMD is influenced by several
variables, including genetic and environmental factors
[16,17]. Thus, reference ranges may vary in different pop-
ulations [18-23], and [24].
Early diagnosis of osteoporosis by assessment of bone
density can prevent its complications, especially fractures.
Bone density relates to many items like race, genetic, sex,
environmental factors and nutrition. In order to define
osteoporosis and osteopenia, knowledge of the reference
data of bone mineral density (BMD) is important. As
there is not any reference data on BMD and osteopenia
and osteoporosis in Iran, we decided to perform a first
national comprehensive study which it's aims of this
study were to determine normal values of bone mineral
density at lumbar vertebras and neck of femur and deter-
mine prevalence of osteopenia and osteoporosis for Ira-
nian normal population.
Methods
This was a cross sectional study. In duration of 6 months,
553 subjects were selected among the men and women of
20_ 69 yr of Tehran. The individuals selected based on
randomized clustered sampling from 50 blocks in Tehran.
For selection of clusters, whole Tehrani's population on
base of distribution of them, divided to many clusters.
From all clusters 50 of them were randomly selected and
after that, in each block, home's numbers whose numbers
were twin were selected on based of exclusion and inclu-
sion criteria, in each home 1 person were selected, until
the individuals in each group reach to 24 persons. The
exclusion criteria were selected from diseases and drugs
that may have effects on metabolism of bone and Vitamin
D. Smoking, alcohol, pregnancy, breast-feeding during
the study, Professional sport, General conditions and
Immobility also were on exclusion criteria.
Healthy individual were selected if they did not have any
problem that affect on bone or Vitamin D metabolism
based on exclusion criteria. Previous and current diseases,
drugs, and habits were determined by personal interview
and were evaluated by nurses through the interview. 750
individuals were invited for this study, 533 individuals
came for assessment. After 2 times recall, there is not any
significant difference between the mean age and sex distri-
bution of individuals who came and who did not come.
217 subjects refused to participate in this study.
The study protocol was approved by research ethic com-
mittee of Endocrinology and Metabolism Research Centre
(EMRC) and the data gathered by cluster random sam-
pling. The subjects with osteoporosis were referred to the
EMRC osteoporosis clinic in the Shariati Hospital for
treatment.
Having received the letters of consent, the related ques-
tionners were completed and clinical examinations such
as height and weight were carried out. BMD was measured
by DXA using Lunar DPX-MD device (Lunar Corporation,
Madison, Wisconsin, 53713. USA). The DXA device was
calibrated daily and weekly by using appropriated phan-
toms methods. To assess BMD, second to fourth lumbar
spine and from the femur bone (neck, trochanter and the
whole femur), bone density was calculated based on gr/
cm2.
SPSS (ver 11.5) was used for data analysis. To compare the
mean, the student T test was used and for comparing fre-
quency of variable between groups Chi-square was used.
Results
553 subjects (34% men, 66% women) between 20 to 69
yr (mean ± SD, 44.07 ± 12.68) participated in the study.
Basic characteristics of the subjects showed that in Table 1.
There was no significant difference in the spinal BMD of
women between the age groups 20–29 and 30–39 (Table
2).
Comparing of BMD between different age decades
showed that; spinal BMD in age group of 40–49, 50–59
and 60–69 in women, 3%, 1% and 4% was less thanBMC Musculoskeletal Disorders 2005, 6:38 http://www.biomedcentral.com/1471-2474/6/38
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previous age decade respectively. In the same age groups,
spinal BMD in men 1%, 6% and 0% was less than previ-
ous age decade. Also, femur BMD in age group of 40–49,
50–59 and 60–69 in women, 5%, 5% and 9%, was less
than previous age decade, and in men 3%, 4% and 3%
was less than previous age decade respectively. (Figure 1,
2).
A significant relationship was found between age and
BMD (P < 0.001 and P < 0.001). There was a significant
relationship (P = 0.025) between BMD and BMI among
the men but there was no relationship of this kind among
the women. On the other hand, there was a significant
relationship between BMI and femur BMD among both
the women and the men (P < 0.001 and P < 0.001 respec-
tively). The loss of BMD among the women was seen
more than after menopause so that during the first ten
years after the menopause, BMD of the spinal column and
femur bone was 1.16 and 2.2 less than each year respec-
tively. In this study, the mean femur BMD among the
women with menopause was 10.5 % lower than the
women without menopause (P < 0.001). The mean spinal
BMD among the women with menopause was 16% lower
than the women without menopause (P < 0.001). In total,
7.4% of all cases in lumbar spine and 2.4% in femur bone
had osteoporosis and 30.4% in the spinal column and
23.9% in femur bone had osteopenia. (Table 3) show the
prevalence of osteoporosis and osteopenia in both sexes
and age groups.
Discussion
In this study, the mean of BMD from spinal column and
femur in all age groups of men were more than that of
women. Most similar studies justify these results through
comparing the fluctuations of androgen level with
Table 1: Basic characteristic of the subjects in each age and sex groups
Age groups Numbers Weight(Kg) Height(cm) BMI(Kg/m2)
mean ± SD mean ± SD mean ± SD
20–29 Women 44 60.1 ± 11.4 160 ± 4.38 23.45 ± 4.1
Men 27 71.27 ± 12.7 173.58 ± 6.16 23.04 ± 3.95
30–39 Women 104 67.43 ± 11.34 156.46 ± 8.29 27.72 ± 5.7
Men 38 77.68 ± 15.99 171.51 ± 7.6 26.29 ± 4.45
40–49 Women 98 70.96 ± 17.58 157.2 ± 6.31 28.61 ± 6.01
Men 48 76.37 ± 10.85 168.11 ± 6.11 27.02 ± 3.55
50–59 Women 82 68.27 ± 11.68 154.04 ± 6.19 28.73 ± 4.74
Men 42 73.66 ± 12.99 166.07 ± 6.15 66.67 ± 4.33
60–69 Women 36 65.67 ± 10.09 152.97 ± 6.72 28.12 ± 4.45
Men 34 72.94 ± 11.73 16312 ± 6.07 27.41 ± 4.23
Table 2: Mean BMDs at the Lumbar Spine and Femur for each Age and Sex groups
Measurement Site Mean BMD in femur (gr/cm2) Mean BMD in Lumbar Spine(gr/cm2)
Age group Women Men Women Men
20–29 0.962 ± 0.132 1.098 ± 0.15 **1.198 ± 0.1132 1.209 ± 0.132
30–39 1.022 ± 0.122 1.042 ± 0.146 1.206 ± 0.1249 1.216 ± 0.1414
40–49 0.968 ± 0.120 1.009 ± 0.144 1.158 ± 0.148 1.202 ± 0.176
50–59 0.9179 ± 0.120 0.966 ± 0.206 1.024 ± 0.178 1.120 ± 0.129
60–69 0.833 ± 0.111 0.935 ± 0.105 0.982 ± 0.161 1.117 ± 0.155
** Mean ± SD
BMD of lumbar spine within age decades and sex (g/cm2) Figure 1
BMD of lumbar spine within age decades and sex (g/cm2).BMC Musculoskeletal Disorders 2005, 6:38 http://www.biomedcentral.com/1471-2474/6/38
Page 4 of 6
(page number not for citation purposes)
estrogen level, in men the level of androgen to estrogen
does not reduce compared with women. On the other
hand, the bone mass, physical activities and peak bone
mass in men were more than women [25,26]. These
results also indicate that the peak bone mass among
women were in age of 30–39 which is in accordance with
other studies [4-7,25-27]. The mean of spinal column
BMD among women 30–39, was 5.6%lower than the
American women, 3.9% more than the Japanese women
6.5% more than Filipino women,,0.06% more than Leba-
nese women [28,29]. There was no significant difference
between these two groups because maximum BMD of Jap-
anese occurs in women of 40–49 [26]. Many studies have
demonstrated that alteration in BMD depends on type of
the bone, different function, menstruation condition,
environmental factors, genetics effects and age [30,31]. As
the results achieved in other countries indicate different
means and amounts, the information obtained through
this study show a similar BMD pattern. The present study
suggests that the maximum BMD of femur bone com-
pared with spinal column occur later. This is justifiable
considering the fact that the maximum BMD in cortical
bone compared with trabecular bone occurs later
[27,30,31]. The amount of BMD of spinal column was
lower of 15.6% after ten years, and this reduction was
16.9% more than the Japanese women [33,35]. The Peak
BMD of total hip within age decades and sex (g/cm2) Figure 2
BMD of total hip within age decades and sex (g/cm2).
Table 3: Prevalence of osteoporosis osteopenia in each age and sex groups
Osteoporosis(%) Osteopenia(%)
Age groups Numbers Spinal column Femur Spinal column Femur
20–29 Women 44 0 2.2 13 17.4
Men 27 3.8 0 23.1 15.4
30–39 Women 104 0 0.9 13.9 8.3
Men 38 2.7 2.7 27 24.3
40–49 Women 98 3.2 2.2 29 15.1
Men 48 4.3 2.1 31.9 31.9
50–59 Women 82 21.8 2.6 46.2 38
Men 42 5.3 5.3 42.1 36.8
60–69 Women 36 32.4 5.9 50 50
Men 34 9.4 3.1 50 46.9BMC Musculoskeletal Disorders 2005, 6:38 http://www.biomedcentral.com/1471-2474/6/38
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bone mass of femur bone was 4.48% less than the Ameri-
can women [34]. The pattern of bone loss, both in femur
and lumbar, depends on the age. The pace of loss in bone
mass up to menopause period, in the women in question,
is similar to the Canadian, British and American women.
Although after that period, it is faster than the women of
Belgium, United Kingdom, France and America whereas it
is less than the Japanese women [32,33].
On the other hand, the rate of bone loss compared with
the other studies (Western Belgian, Japanese,) is either the
same or more [32-35]. This trend, therefore, caused an
increase in incidence of osteoporosis and osteopenia. In
men, the peak bone mass in spinal column was 3.5% less
than the American men [7]. The incidence of osteoporosis
and osteopenia among women and men was 32.4% and
9.4% respectively, which is more than of Lebanese and
Thai women and less than Hong Kong and US women,
this is justifiable with regard to the above-mentioned
explanations. Studies indicate that the peak bone mass
plays an important role the incidence of osteoporosis
which this peak bone mass depends on genetics, kind of
diet, sport and the hormonal state. Genetics was the most
important factor justifying low BMD in our study. As well,
with respect to the deficiency of vitamin D in Iran, which
is common among 80% of people in some areas, and also
lack of enough activity, in particular, among young girls of
20–29 can cause the low level of bone mass [7].
Conclusion
It is notice-worthy that this paper represents the early
results of the comprehensive plan for prevention, diagno-
sis and treatment of osteoporoses carried out in the EMRC
of Tehran University of Medical Sciences, which is still
being conducted and is not finished yet. With completing
the project and data gathering and studying all patients
fully, the final results could be achieved and the relation-
ships could be analytically discussed. Broadly speaking,
the present study indicates the high incidence of oste-
oporosis and osteopenia among the Tehran population,
which requires our proper attention and planning for pre-
vention. Also, the low amount of peak bone mass in the
ages 20–39 is helpful to adopt an adequate strategy in this
respect. There are many factors involved in this maximum
BMD including genetic factors, body activity and provid-
ing enough vitamin D and calcium.
Among the intervening factors, enough nutrition together
with calcium and vitamin D could be enumerated. The
results of this study indicate that there is an increase in
bone mass in the first decade after menopause requiring a
proper treatment during the years before and after
menopause.
The limitations of this study are the following points. This
is the primary result of the national comprehensive study
of osteoporosis in Iran. The individuals excluded from
this study based on personal interview and their statement
about their disease, not documented diagnostic diseases.
In addition, the data of this study limited to Tehran and,
our data assumed as an estimation of reference data in
Iran. For demonstration of Iran's data, a bigger study is
needed.
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